NDC 0074-6214

Depakote

Divalproex Sodium

Depakote is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Abbvie Inc.. The primary component is Divalproex Sodium.

Product ID0074-6214_1e5edafb-116d-085d-ec76-cc604b863c8d
NDC0074-6214
Product TypeHuman Prescription Drug
Proprietary NameDepakote
Generic NameDivalproex Sodium
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date1983-03-10
Marketing CategoryNDA / NDA
Application NumberNDA018723
Labeler NameAbbVie Inc.
Substance NameDIVALPROEX SODIUM
Active Ingredient Strength250 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0074-6214-13

100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-6214-13)
Marketing Start Date1983-03-10
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0074-6214-11 [00074621411]

Depakote TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA018723
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-03-10
Marketing End Date2012-11-14

NDC 0074-6214-71 [00074621471]

Depakote TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA018723
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-06-08
Marketing End Date2012-11-14

NDC 0074-6214-13 [00074621413]

Depakote TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA018723
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1983-03-10

NDC 0074-6214-53 [00074621453]

Depakote TABLET, DELAYED RELEASE
Marketing CategoryNDA
Application NumberNDA018723
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1983-03-10

Drug Details

Active Ingredients

IngredientStrength
DIVALPROEX SODIUM250 mg/1

OpenFDA Data

SPL SET ID:08a65cf4-7749-4ceb-6895-8f4805e2b01f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1099871
  • 1099870
  • 1099679
  • 1099625
  • 1099626
  • 1099678
    • UPC Code
  • 0300746214533
  • 0300746215134
  • 0300746212133

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Mood Stabilizer [EPC]

    NDC Crossover Matching brand name "Depakote" or generic name "Divalproex Sodium"

    NDCBrand NameGeneric Name
    0074-3826DepakoteDivalproex Sodium
    0074-6114DepakoteDivalproex Sodium
    0074-6212DepakoteDivalproex Sodium
    0074-6214DepakoteDivalproex Sodium
    0074-6215DepakoteDivalproex Sodium
    0074-7126DepakoteDivalproex Sodium
    70518-1456DepakoteDepakote
    70518-1454DepakoteDepakote
    21695-359DepakoteDepakote
    21695-163DepakoteDepakote

    Trademark Results [Depakote]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DEPAKOTE
    DEPAKOTE
    75295484 2197507 Dead/Cancelled
    SANOFI-AVENTIS
    1997-05-21
    DEPAKOTE
    DEPAKOTE
    73383028 1377834 Live/Registered
    SANOFI
    1982-09-01
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.